STOCK TITAN

CME Group (CME) amends $7B multi-currency clearing credit facility

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

CME Group Inc., through its subsidiary Chicago Mercantile Exchange Inc., entered into Amendment No. 11 to its 364-day multi-currency credit facility with a syndicate of banks led by Bank of America and Citibank. The amended facility provides a $7 billion multi-currency revolving secured credit line, which is eligible to be increased to $10 billion. It is intended to provide temporary liquidity if a clearing firm or depositary fails to meet obligations, or if there is a disruption in the domestic payments system affecting settlements between CME and its clearing firms. Cash and U.S. Treasury guaranty fund contributions, along with performance bond assets under the CME rulebook, may be used as collateral, and CME must comply with a consolidated tangible net worth test.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Facility size $7 billion Multi-currency revolving secured credit facility
Upsize option $10 billion Maximum eligible size of credit facility
Facility term 364-day Duration of multi-currency credit facility
Amendment number Amendment No. 11 Latest amendment to credit agreement
Effective date April 22, 2026 Effective date of Amendment No. 11
multi-currency revolving secured credit facility financial
"The Existing 364-Day Credit Facility is for a multi-currency revolving secured credit facility of $7 billion"
Clearing House Credit Facility financial
"Clearing House Credit Facility Effective as of April 22, 2026, Chicago Mercantile Exchange Inc. entered into an amendment"
clearing firm guaranty fund contributions financial
"Clearing firm guaranty fund contributions received in the form of cash or U.S. Treasury securities"
performance bond assets financial
"as well as the performance bond assets (pursuant to the CME rulebook) can be used to collateralize the facility"
consolidated tangible net worth test financial
"The Existing 364-Day Credit Facility contains a requirement that CME remain in compliance with a consolidated tangible net worth test"
false000115637500011563752026-04-222026-04-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
_________________________________________________________
FORM 8-K
 
_________________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) April 27, 2026 (April 22, 2026)
 
 _________________________________________________________
CME GROUP INC.
(Exact Name of Registrant as Specified in its Charter) 
_________________________________________________________ 
Delaware 001-31553 36-4459170
(State or Other Jurisdiction
of Incorporation)
 (Commission
File No.)
 (IRS Employer
Identification No.)
 
20 South Wacker DriveChicagoIllinois 60606
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (312930-1000
N/A
(Former Name or Former Address, if Changed Since Last Report) 
______________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Class A Common StockCMENasdaq
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01Entry into a Material Definitive Agreement.
Clearing House Credit Facility

Effective as of April 22, 2026, Chicago Mercantile Exchange Inc. ("CME") entered into an amendment ("Amendment No. 11") to its 364-day multi-currency credit facility (the "364-Day Credit Facility") with Bank of America, N.A., in its capacity as Administrative Agent, Citibank, N.A., in its capacity as Collateral Agent and Collateral Monitoring Agent, and the banks party thereto. The 364-Day Credit Facility as amended by Amendment No. 11 is referred to as the "Existing 364-Day Credit Facility."

The Existing 364-Day Credit Facility is for a multi-currency revolving secured credit facility of $7 billion (which is eligible to be increased to $10 billion). The proceeds of the Existing 364-Day Credit Facility may be used to provide temporary liquidity in the unlikely event a clearing firm fails to promptly discharge an obligation to the clearing house operated by CME, in the event of a liquidity constraint or default by a depositary (custodian for our collateral), in the event of a temporary disruption with the domestic payments system that would delay payment of settlement variation between CME and its clearing firms, or in other cases as provided by the CME rulebook. Clearing firm guaranty fund contributions received in the form of cash or U.S. Treasury securities as well as the performance bond assets (pursuant to the CME rulebook) can be used to collateralize the facility. The Existing 364-Day Credit Facility contains a requirement that CME remain in compliance with a consolidated tangible net worth test.

The foregoing description of the Existing 364-Day Credit Facility is only a summary, does not purport to be complete and is qualified in its entirety by reference to, and should be read in conjunction with, the complete text of the Existing 364-Day Credit Facility, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

 

Item 9.01Financial Statements and Exhibits.
    
Exhibit
Number    
  Description
10.1
Amendment No. 11 to Credit Agreement, dated as of April 22, 2026, among Chicago Mercantile Exchange Inc., certain lenders, Bank of America, N.A., as Administrative Agent, and Citibank, N.A., as Collateral Agent and Collateral Monitoring Agent.
104The cover page from CME Group Inc.’s Current Report on Form 8-K, formatted in Inline XBRL.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



 
 CME Group Inc.
 Registrant
Date: April 27, 2026 By: /s/ Lynne Fitzpatrick
 Name:

Title:
 Lynne Fitzpatrick

Senior Managing Director, President and Chief Financial Officer

Principal Financial Offer and
Duly Authorized Officer
  

FAQ

What credit facility amendment did CME (CME) report in this 8-K?

CME’s subsidiary entered Amendment No. 11 to its 364-day multi-currency revolving secured credit facility. The arrangement updates terms with Bank of America, Citibank, and other lenders, maintaining a large backstop for clearing house liquidity needs.

What is the size of CME’s amended clearing house credit facility?

The amended credit facility provides a $7 billion multi-currency revolving secured credit line. It is also eligible to be increased to $10 billion, giving CME additional flexibility to address potential short‑term liquidity issues in its clearing operations.

How does CME plan to use the 364-day credit facility?

The facility may be used to provide temporary liquidity if a clearing firm fails to meet obligations, if a depositary faces liquidity constraints, or if payments system disruptions delay settlement variation between CME and its clearing firms, as outlined in the CME rulebook.

What collateral can secure CME’s clearing house credit facility?

Collateral can include clearing firm guaranty fund contributions received as cash or U.S. Treasury securities, as well as performance bond assets. These assets, defined under the CME rulebook, can be pledged to secure borrowings under the credit facility when needed.

What financial covenant applies to CME under this credit facility?

The credit facility requires CME to comply with a consolidated tangible net worth test. This covenant means CME must maintain tangible net worth above a specified level, supporting lender protections and the ongoing availability of the liquidity backstop arrangement.

Filing Exhibits & Attachments

4 documents